Permanent Pacemaker Placement Secondary to Remdesivir Induced Bradycardia: A Case Report

Remdesivir is approved by the FDA for the treatment of hospitalized coronavirus disease 2019 (COVID-19) patients. It is known to be associated with transient bradycardia that resolves after discontinuation of the drug. We present a case of a 71-year-old male with a history of congestive heart failur...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shahkar, Mustafa, Ahmad, Elhosseiny, Sherif M, Rizvi, Taqi, Lafferty, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710722/
https://www.ncbi.nlm.nih.gov/pubmed/36465748
http://dx.doi.org/10.7759/cureus.30923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710722/
https://www.ncbi.nlm.nih.gov/pubmed/36465748
http://dx.doi.org/10.7759/cureus.30923

Ejemplares similares